Agricultural Biotechnology Market Research Report by Crop Type (Cereals & Grains, Fruits & Vegetables, and Macroindicators), Type, Product Type, Mode of Application, Function, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19
New York, April 13, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Agricultural Biotechnology Market Research Report by Crop Type, Type, Product Type, Mode of Application, Function, Application, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19" – https://www.reportlinker.com/p06262307/?utm_source=GNW
The Global Agricultural Biotechnology Market size was estimated at USD 37.94 billion in 2021 and expected to reach USD 42.21 billion in 2022, and is projected to grow at a CAGR 11.42% to reach USD 72.62 billion by 2027.
The report provides market sizing and forecast across five major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Agricultural Biotechnology to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Crop Type, the market was studied across Cereals & Grains, Fruits & Vegetables, Macroindicators, and Oilseeds & Pulses.
Based on Type, the market was studied across Animals, Microbes, and Plants. The Animals is further studied across Conventional Techniques, Established Genetic Modification, and New Breeding Techniques. The Microbes is further studied across Conventional Techniques, Established Genetic Modification, and New Breeding Techniques. The Plants is further studied across Conventional Techniques, Established Genetic Modification, and New Breeding Techniques.
Based on Product Type, the market was studied across Macrobials, Microbials, Natural Products, and Semichemicals.
Based on Mode of Application, the market was studied across Foliar Spray, Seed Treatment, and Soil Treatment.
Based on Function, the market was studied across Crop Enhancement and Crop protection. The Crop Enhancement is further studied across Biofertilizers and Biostimulants. The Crop protection is further studied across Biocontrol.
Based on Application, the market was studied across Antibiotic Development, Biofuels, Flower Culturing, Nutritional Supplements, Transgenic Crops & Animals, and Vaccine Development.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.
This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Agricultural Biotechnology market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Agricultural Biotechnology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Agricultural Biotechnology Market, including BASF SE, Bayer AG, Benson Hill Inc., Biolchim S.p.A, Certis USA L.L.C., Corteva, Inc., DuPont de Nemours, Inc., Evogene Ltd., Isagro Group, Marrone Bio Innovations, Inc., Nufarm Limited, Syngenta AG, Valent BioSciences LLC, Vilmorin & Cie S.A, and Yield10 Bioscience, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Agricultural Biotechnology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Agricultural Biotechnology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Agricultural Biotechnology Market?
4. What is the competitive strategic window for opportunities in the Global Agricultural Biotechnology Market?
5. What are the technology trends and regulatory frameworks in the Global Agricultural Biotechnology Market?
6. What is the market share of the leading vendors in the Global Agricultural Biotechnology Market?
7. What modes and strategic moves are considered suitable for entering the Global Agricultural Biotechnology Market?
Read the full report: https://www.reportlinker.com/p06262307/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
OMAHA, Neb. (Reuters) -Warren Buffett on Saturday used the annual meeting of Berkshire Hathaway Inc to rail against Wall Street excess and extol the virtues of cash after rapidly spending tens of billions on stocks and companies, while addressing the risk to his conglomerate from the threat of nuclear war. The meeting in downtown Omaha, Nebraska was Berkshire's first welcoming shareholders since 2019, before COVID-19 derailed America's largest corporate gathering for two years. It allowed shareholders to ask questions directly to Buffett and Berkshire Vice Chairmen Charlie Munger, Greg Abel and Ajit Jain.
Health officials declared Covid-19 a global pandemic and planes stopped flying, bars, gyms and theaters closed, and people retreated to their homes to wait out the disease that had thoroughly disrupted their lives. Companies like Teladoc Health , Zoom Video Communications , Netflix and Peloton Interactive made the most out of social distancing. Netflix posted the first decline in annual subscriber growth in more than a decade earlier this month.
April showers apparently bring dramatically lower markets on Wall Street, and this month's slump for the S&P 500 was a doozy.
Judging by his investments in Chevron and Occidental Petroleum, Buffett seems to be focusing on "shareholder yield." Investors should pay attention.
Bay Street Capital Holdings CIO William Huston and Ted Oakley, Oxbow Advisors Managing Partner, join Yahoo Finance Live to examine this week's bear market indicators, Nasdaq outlook, inflation, the Fed's interest rate hikes, and crypto and digital asset investments.
Elon Musk reportedly has some new plans for Twitter's C-suite. The Tesla CEO whose recent $44 billion bid to acquire Twitter was accepted is now putting plans in place for a new CEO at the San Francisco company, according to Reuters, which reported that Musk has decided on who he plans to appoint but has yet to publicly release the name. Musk reportedly reiterated to Twitter Chairman Bret Taylor that he isn't confident regarding the company’s management — a tone he had struck in his earlier SEC filings — and he also told banks that he plans to create a way to monetize tweets that go viral or include important information and suggested charging a fee when third-party websites quote or embed tweets from verified accounts.
Low rates and high inflation make cash tough to hold. Look here instead.
Berkshire Hathaway Vice Chairman Charlie Munger did some kicking of a downed dog on Saturday.
By the end of trading on Friday, the selloff had gotten worse and we were staring at the worst start to a year since the Great Depression.
Warren Buffett and the rest of Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) senior leadership team welcomed tens of thousands of investors back to Omaha this weekend for the company's first in-person shareholder meeting since 2019. With that, here are some of the most important takeaways from the report, and why Berkshire's earnings report doesn't tell the whole story. Berkshire's earnings declined … or did they?
E-commerce giant Amazon and automaker Ford both have stakes in a company that is becoming a financial headache.
The Berkshire CEO and company Vice Chairman Charlie Munger told shareholders why they put billions to work buying stocks, including Chevron and Activision Blizzard: "We found some things we preferred owning to Treasury bills.”
In this article, we discuss the 12 safe stocks to buy for beginner investors. You can skip our detailed analysis of these stocks and the current market situation, and go directly to 5 Safe Stocks To Buy For Beginner Investors. Economic forecasts can be incredibly fickle, and although the past few years have proven that […]
It's been a sad week for Warner Bros. Discovery, Inc. ( NASDAQ:WBD ), who've watched their investment drop 12% to…
At the Berkshire Hathaway annual meeting, the CEO shared his thoughts on the state of the markets, Berkshire’s insurance business and recent investments.
(Reuters) -Twitter Chief Executive Parag Agrawal sought to quell employee anger on Friday during a company-wide meeting where employees demanded answers to how managers planned to handle an anticipated mass exodus prompted by Elon Musk. The meeting comes after Musk, the Tesla chief executive who sealed a $44 billion deal to buy the social media company, repeatedly criticized Twitter's content moderation practices and a top executive responsible for setting speech and safety policies. At the internal town hall meeting, which was heard by Reuters, executives said the company would monitor staff attrition daily, but it was too soon to tell how the buyout deal with Musk would affect staff retention.
It's been an even tougher go for the growth-focused Nasdaq Composite (NASDAQINDEX: ^IXIC), which has lost more than 20% of its value since hitting a record high in mid-November. This puts the widely followed Nasdaq in a bear market. Without question, bear markets can be scary.
The energy industry has had its ups and downs in recent years. Because of that, it hasn't always been the best place to go for those looking for a sustainable passive income stream. Because of that, investors seeking income should take a closer look at this part of the oil patch.
Economic growth was starting to slow after a solid rebound from early effects of the pandemic in 2021, but Russia's invasion of Ukraine added to that slowdown. The Federal Reserve's promise to aggressively hike interest rates this year in an attempt to fight inflation is only adding to the worry.
Shares of Nio (NYSE: NIO) surged Friday morning as investors took note of the company's 20F annual report filed today and some good news coming in from China, Nio's domestic market. Investors might know that foreign stocks, particularly Chinese stocks, face the threat of being delisted from U.S. stock exchanges if the underlying companies fail to comply with the audit rules as outlined by the U.S. Securities and Exchange Commission (SEC) under the Holding Foreign Companies Accountable Act (HFCAA). Under the law, foreign companies whose audit reports haven't been accessible for the Public Company Accounting Oversight Board (PCAOB) to inspect for three years at a stretch will be asked to delist their shares in the U.S. The SEC recently started identifying and naming such companies publicly.